tradingkey.logo
搜索

Sarepta Therapeutics Inc

SRPT
添加自选
14.860USD
-0.700-4.50%
收盘 07-31 16:00美东报价延迟15分钟
1.57B总市值
23.85市盈率 TTM

SRPT 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Sarepta Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Sarepta Therapeutics Inc财报日历

最新发布
8月 5, 2026
每股收益 / 预测值
--/0.26
营业收入 / 预测值
--/364.34M
报告期
FY2025 财报
营业收入(YoY)
2.20B
15.58%
每股收益(YoY)
-7.13
-387.99%
分析师评级
HOLD
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
168.58%3.15
-263.33%-2.70
-609.50%-1.80
2842.73%2.01
-1296.09%-4.60
275.41%1.65
176.51%0.35
125.31%0.07
106.56%0.38
135.38%0.44
---0.46
---0.27
---5.86
---1.24
---6.79
----
----
----
----
----
营业收入
-1.89%730.80M
-32.73%442.93M
-14.52%399.36M
68.38%611.09M
80.15%744.86M
65.94%658.41M
40.79%467.17M
38.93%362.93M
63.10%413.46M
53.54%396.78M
44.10%331.82M
11.89%261.24M
20.24%253.50M
28.28%258.43M
21.57%230.27M
42.29%233.49M
43.49%210.83M
38.81%201.46M
31.60%189.41M
19.46%164.09M
净利润
173.96%330.96M
-277.84%-282.85M
-635.38%-179.95M
2947.86%196.89M
-1338.98%-447.51M
248.37%159.05M
182.10%33.61M
126.98%6.46M
106.99%36.12M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.75M
10.44%-109.24M
-435.35%-257.74M
-184.36%-231.48M
37.20%-105.03M
35.57%-121.98M
75.50%-48.14M
46.03%-81.41M
利润率
175.38%45.29%
-364.35%-63.86%
-726.30%-45.06%
1710.15%32.22%
-787.75%-60.08%
109.94%24.16%
158.32%7.19%
119.42%1.78%
104.29%8.74%
127.22%11.51%
---12.34%
---9.16%
---203.85%
---42.27%
---88.09%
----
----
----
----
----
毛利率
4.38%85.02%
-40.92%47.15%
-22.64%62.08%
-14.43%74.93%
-7.05%81.45%
-9.99%79.81%
-9.54%80.24%
0.80%87.56%
1.75%87.63%
0.75%88.67%
--88.71%
--86.87%
--86.12%
--88.01%
--83.73%
----
----
----
----
----
资产负债率
-19.73%26.37%
-13.75%24.75%
-13.10%29.63%
-13.54%30.97%
-14.53%32.85%
-24.34%28.69%
-14.26%34.10%
-9.39%35.81%
-4.72%38.43%
-23.18%37.92%
--39.77%
--39.53%
--40.34%
--49.36%
--48.88%
----
----
----
----
----
营业收入
-1.89%730.80M
-32.73%442.93M
-14.52%399.36M
68.38%611.09M
80.15%744.86M
65.94%658.41M
40.79%467.17M
38.93%362.93M
63.10%413.46M
53.54%396.78M
44.10%331.82M
11.89%261.24M
20.24%253.50M
28.28%258.43M
21.57%230.27M
42.29%233.49M
43.49%210.83M
38.81%201.46M
31.60%189.41M
19.46%164.09M
营业利润
219.32%358.43M
-251.40%-244.78M
-383.29%-62.88M
16587.45%115.58M
-960.58%-300.39M
556.57%161.68M
206.50%22.20M
99.47%-701.00K
125.28%34.91M
123.05%24.63M
84.13%-20.84M
36.76%-133.52M
-58.94%-138.09M
-0.96%-106.83M
-281.20%-131.35M
-25.99%-211.13M
38.76%-86.88M
38.02%-105.81M
74.86%-34.46M
-21.12%-167.57M
净利润
173.96%330.96M
-277.84%-282.85M
-635.38%-179.95M
2947.86%196.89M
-1338.98%-447.51M
248.37%159.05M
182.10%33.61M
126.98%6.46M
106.99%36.12M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.75M
10.44%-109.24M
-435.35%-257.74M
-184.36%-231.48M
37.20%-105.03M
35.57%-121.98M
75.50%-48.14M
46.03%-81.41M
流动资产
-5.04%2.31B
-17.42%2.54B
1.38%2.72B
-0.99%2.66B
-1.31%2.43B
19.16%3.07B
9.57%2.69B
8.53%2.68B
-0.94%2.46B
0.84%2.58B
-6.67%2.45B
0.13%2.47B
-1.68%2.49B
-1.78%2.56B
20.16%2.63B
9.01%2.47B
11.43%2.53B
4.78%2.60B
-5.91%2.19B
-7.90%2.27B
流动负债总额
-17.57%499.16M
49.69%1.10B
31.73%921.42M
33.62%919.95M
-0.51%605.59M
11.94%731.68M
55.19%699.49M
38.07%688.49M
13.38%608.71M
5.50%653.66M
-25.24%450.74M
-8.60%498.65M
18.01%536.88M
36.86%619.60M
61.45%602.92M
28.36%545.57M
24.74%454.96M
8.82%452.73M
-1.31%373.44M
19.76%425.02M
总资产
-8.27%3.18B
-15.48%3.35B
-2.96%3.49B
7.46%3.68B
7.47%3.47B
21.40%3.96B
15.76%3.60B
9.55%3.42B
5.38%3.22B
4.35%3.26B
-1.47%3.11B
4.31%3.13B
0.12%3.06B
-0.62%3.13B
18.55%3.16B
8.62%3.00B
10.52%3.06B
5.47%3.15B
-4.26%2.66B
-4.30%2.76B
总负债
-27.93%1.67B
-9.29%2.21B
-8.64%2.17B
-1.05%2.32B
2.63%2.32B
1.26%2.44B
1.43%2.38B
-1.56%2.35B
-3.57%2.26B
-12.33%2.41B
-13.94%2.35B
5.02%2.38B
6.72%2.35B
23.58%2.74B
24.29%2.73B
-0.16%2.27B
-1.37%2.20B
-0.13%2.22B
16.10%2.19B
23.57%2.27B
总权益
31.71%1.51B
-25.34%1.14B
8.11%1.32B
26.03%1.36B
18.89%1.14B
77.78%1.53B
59.75%1.22B
45.27%1.08B
34.86%961.19M
123.23%859.34M
77.41%764.36M
2.06%741.41M
-16.82%712.75M
-58.52%384.95M
-8.24%430.84M
49.75%726.46M
60.03%856.89M
21.82%928.01M
-47.37%469.53M
-53.48%485.11M
经营净额
65.26%-202.68M
42.54%131.21M
79.37%-14.59M
1649.01%261.34M
-141.01%-583.44M
268.41%92.05M
38.37%-70.70M
112.22%14.94M
-15.61%-242.08M
40.84%-54.66M
-76.57%-114.71M
-82.94%-122.23M
-106.96%-209.40M
-215.05%-92.39M
47.75%-64.96M
38.78%-66.81M
43.91%-101.17M
83.20%-29.33M
47.80%-124.33M
-1.43%-109.15M
投资净额
53.85%-134.39M
-87.41%96.21M
280.40%232.40M
132.69%32.21M
-233.08%-291.18M
1287.29%764.12M
38.82%-128.82M
-201.96%-98.53M
1651.49%218.80M
-756.98%-64.36M
-1201.37%-210.57M
133.32%96.63M
101.59%12.49M
480.13%9.80M
-5.66%19.12M
-190.32%-289.99M
-601.58%-785.81M
97.92%-2.58M
-62.52%20.27M
1038.08%321.06M
融资净额
-98.07%241.00K
-180.03%-39.21M
-956.22%-117.79M
-159.66%-23.82M
-43.67%12.47M
2421.41%48.99M
-10.70%13.76M
581.08%39.92M
-78.25%22.14M
-81.92%1.94M
-92.88%15.40M
1628.91%5.86M
1939.98%101.80M
-98.04%10.75M
3567.05%216.43M
-90.39%339.00K
72.49%4.99M
68.00%549.25M
-68.59%5.90M
-79.94%3.53M

常见问题

Sarepta Therapeutics Inc的总收入是多少?

根据Sarepta Therapeutics Inc的FY2025财报,总收入达到了2.20B(同比变化1.90B)。

Sarepta Therapeutics Inc的流动资产是多少?

根据Sarepta Therapeutics Inc的FY2025财报,流动资产为2.54B(同比变化-17.42)。

Sarepta Therapeutics Inc的总资产是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的总资产为3.35B(同比变化-15.48)。

Sarepta Therapeutics Inc的总负债是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的总负债为2.21B(同比变化-9.29)。

Sarepta Therapeutics Inc的总权益是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的总权益为1.14B(同比变化-25.34)。

Sarepta Therapeutics Inc的净营业收入是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的净营业收入为-492.47M(同比变化-325.82)。

Sarepta Therapeutics Inc的净投资是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的净投资为69.64M(同比变化-90.78)。

Sarepta Therapeutics Inc的净融资是多少?

根据Sarepta Therapeutics Inc的FY2025财报,Sarepta Therapeutics Inc的净融资为-168.34M(同比变化-234.88)。

Sarepta Therapeutics Inc的每股收益(EPS)是多少?

根据Sarepta Therapeutics Inc的FY2025财报,每股收益(EPS)为-7.13(同比变化-387.99)。

Sarepta Therapeutics Inc的净利润是多少?

根据Sarepta Therapeutics Inc的FY2025财报,净利润为-713.41M(同比变化-403.27)。

Sarepta Therapeutics Inc的净利润率是多少?

根据Sarepta Therapeutics Inc的FY2025财报,净利润率为-32.45(同比变化-362.40)。

Sarepta Therapeutics Inc的毛利率是多少?

根据Sarepta Therapeutics Inc的FY2025财报,毛利率为69.21(同比变化-16.72)。

Sarepta Therapeutics Inc的债务与资产比率是多少?

根据Sarepta Therapeutics Inc的FY2025财报,债务与资产比率为24.75(同比变化-13.75)。

Sarepta Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Sarepta Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-53.47(同比变化-371.30)。

Sarepta Therapeutics Inc的资产回报率(ROA)是多少?

根据Sarepta Therapeutics Inc的FY2025财报,资产回报率(ROA)为-19.51(同比变化-399.74)。

Sarepta Therapeutics Inc的营业利润是多少?

根据Sarepta Therapeutics Inc的FY2025财报,营业利润为-492.47M(同比变化-325.82)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有